The effect of dry needling in subjects with fibromyalgia with low back pai

Not Applicable

Recruiting

Conditions: Condition 1: Fibromyalgia. Condition 2: Chronic Nonspecific Low Back Pain.
Fibromyalgia
Low back pain
M79.7
M54.5

Registration Number: IRCT20191208045652N7

Lead Sponsor: Iran University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 30

Inclusion Criteria

People aged 18 to 65
Fibromyalgia diagnosed by a rheumatologist
The pain should be between the edge of the 12th rib and the lower gluteal fold
The duration of pain is more than three months
The minimum Visual analogue scale at the time of visit should be 3 out of 10
Patients have trigger points in the multifidus, quadratus lumborum and gluteus medius muscles
Have a minimum Oswestry Disability Index score of 20 out of 100
The participants should be able to understand and read Persian language in order to fill the questionnaire

Exclusion Criteria

Spinal and pelvic pathologies such as fracture, infection and tumor
Presence of systemic infection
Coagulation and bleeding disorders
Presence of lymphedema or removal of lymph nodes
pregnancy
The presence of a pacemaker
Severe respiratory and cardiovascular disorders
epilepsy
History of trauma to the lumbopelvic region
History of surgery in the lumbopelvic region
Lumbar radiculopathy
Dry needling treatment in the last 6 months
Cognitive impairment
Needle phobia
Uncontrolled diabetes
Systemic joint disease such as rheumatoid arthritis
Symptoms of radiculopathy and pressure on the nerve root
Cauda equina? syndrome
Spondyloarthropathies
Metal pins or prosthetic joints
Inability to communicate with the patient

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain. Timepoint: The first session before treatment, the fourth session before the start of the treatment, the sixth session before the start of the treatment, one month after the last treatment session, three months after the last treatment session. Method of measurement: Visual Analogue Scale.

Secondary Outcome Measures

Name	Time	Method
Muscle performance. Timepoint: The first session before treatment, the sixth session before the start of the treatment, one month after the last treatment session. Method of measurement: dynamometer and Isometric test of neck flexor muscles.;Pressure pain threshold. Timepoint: The first session before treatment, the sixth session before the start of the treatment, one month after the last treatment session. Method of measurement: Algometer.;Functional disability. Timepoint: The first session before treatment, the sixth session before the start of the treatment, one month after the last treatment session. Method of measurement: Oswestry disability index.;Central sensitization. Timepoint: The first session before treatment, the sixth session before the start of the treatment, one month after the last treatment session. Method of measurement: fibromyalgia 2011 questionnaire, Algometer.